Papers on GLP-1-based therapies
13 papers8 new in 30 days
Sunday, November 8
Saturday, November 7
AHA Scientific Sessions 2026 Abstract
Blood Pressure Effects of Glucagon-Like Peptide-1-Based Therapies: The Untapped Need for Dedicated Hypertension Trials
Systematic review of randomized trialsGlp-1-based therapies
Thursday, November 5
Diabetology & Metabolic Syndrome
Comparative effects of glucagon-like peptide-1-based regimens on peripheral arterial and limb events in type 2 diabetes: a network meta-analysis of randomized trials
Meta-analysis of randomized trialsType 2 diabetes
Monday, November 2
Friday, October 30
Frontiers in Endocrinology
Hypertensive type 2 diabetes across the cardio-renal-hepatic-metabolic continuum: a precision-medicine framework for therapeutic decision-making
Accepted, not yet published: reviewResistant hypertension
Friday, October 23
Thursday, October 15
Frontiers in Cardiovascular Medicine
GLP-1-Based therapies for obesity-related heart failure with preserved ejection fraction: an umbrella review incorporating broader heart failure and cardiometabolic evidence
Systematic reviewGlp-1-based therapies
Friday, October 2
Saturday, September 26
European Journal of Internal Medicine
Multiorgan protective therapy for CKM syndrome: the role of GLP-1-based therapies and SGLT2 inhibitors
ReviewSGLT2 inhibitors